Cargando…

Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells

Emerging evidence suggests that the adenosine A2b receptor (ADORA2B, also known as A2bR) plays a pivotal role in tumor progression. We have recently demonstrated that blocking A2bR stimulates T cell-mediated immunosurveillance in a melanoma model by impairing the influx of myeloid-deriver suppressor...

Descripción completa

Detalles Bibliográficos
Autores principales: Morello, Silvana, Miele, Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121336/
https://www.ncbi.nlm.nih.gov/pubmed/25101221
http://dx.doi.org/10.4161/onci.27989
_version_ 1782329219800367104
author Morello, Silvana
Miele, Lucio
author_facet Morello, Silvana
Miele, Lucio
author_sort Morello, Silvana
collection PubMed
description Emerging evidence suggests that the adenosine A2b receptor (ADORA2B, also known as A2bR) plays a pivotal role in tumor progression. We have recently demonstrated that blocking A2bR stimulates T cell-mediated immunosurveillance in a melanoma model by impairing the influx of myeloid-deriver suppressor cells (MDSCs) into the tumor microenvironment. This results in robust antineoplastic effects, which can be abrogated by the adoptive transfer of MDSCs.
format Online
Article
Text
id pubmed-4121336
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-41213362015-02-14 Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells Morello, Silvana Miele, Lucio Oncoimmunology Author's View Emerging evidence suggests that the adenosine A2b receptor (ADORA2B, also known as A2bR) plays a pivotal role in tumor progression. We have recently demonstrated that blocking A2bR stimulates T cell-mediated immunosurveillance in a melanoma model by impairing the influx of myeloid-deriver suppressor cells (MDSCs) into the tumor microenvironment. This results in robust antineoplastic effects, which can be abrogated by the adoptive transfer of MDSCs. Landes Bioscience 2014-02-14 /pmc/articles/PMC4121336/ /pubmed/25101221 http://dx.doi.org/10.4161/onci.27989 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Morello, Silvana
Miele, Lucio
Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
title Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
title_full Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
title_fullStr Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
title_full_unstemmed Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
title_short Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
title_sort targeting the adenosine a2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121336/
https://www.ncbi.nlm.nih.gov/pubmed/25101221
http://dx.doi.org/10.4161/onci.27989
work_keys_str_mv AT morellosilvana targetingtheadenosinea2breceptorinthetumormicroenvironmentovercomeslocalimmunosuppressionbymyeloidderivedsuppressorcells
AT mielelucio targetingtheadenosinea2breceptorinthetumormicroenvironmentovercomeslocalimmunosuppressionbymyeloidderivedsuppressorcells